[1] Feng ZJ. Vaccine policy as evidence-based public health decision making in action. China CDC Weekly 2019;1(2):17-8. http://weekly.chinacdc.cn/en/article/id/b27246e0-6041-42f7-a288-4f64baffbba6.http://weekly.chinacdc.cn/en/article/id/b27246e0-6041-42f7-a288-4f64baffbba6
[2] Ma C, Rodewald L, An ZJ, Yin ZD, Feng ZJ. The National Immunization Advisory Committee in China: roles of national experts in making evidence-based recommendations for immunization. China CDC Weekly 2019;1(2):28-30. http://weekly.chinacdc.cn/en/article/id/76141c5c-5185-4596-bb57-b1c3b5c2501d.http://weekly.chinacdc.cn/en/article/id/76141c5c-5185-4596-bb57-b1c3b5c2501d
[3] Draft landscape of COVID-19 candidate vaccines – 11 April, 2020. https://www.who.int/blueprint/priority-diseases/key-action/Novel_Coronavirus_Landscape_nCoV_11April2020.PDF?ua=10.PDF?ua=1.[2020-04-12]. https://www.who.int/blueprint/priority-diseases/key-action/Novel_Coronavirus_Landscape_nCoV_11April2020.PDF?ua=10.PDF?ua=1